Europe ' s Biggest Private Biotech Company Raises $270 Million Europe ' s Biggest Private Biotech Company Raises $270 Million
Europe ' s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to support its work in developing personalized immunotherapies for cancer, ahead of an expected eventual stock market flotation.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
More News: Allergy | Allergy & Immunology | Biotechnology | Cancer | Cancer & Oncology | Germany Health | Immunotherapy